← FDA Drug Approvals (Drugs@FDA)
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
NDA · New Drug Application · Sponsor: LONG GROVE PHARMS · Approved 2022-10-06
Drug application
- FDA Application #
NDA214628- Application type
- New Drug Application
- Brand name
- NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
- Generic name
- NOREPINEPHRINE BITARTRATE
- Active ingredients
- NOREPINEPHRINE BITARTRATE
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- LONG GROVE PHARMS
- Manufacturer
- Long Grove Pharmaceuticals, LLC
- First approval
- 2022-10-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown